[1]
2022. Detection of TP53 mutations in plasma of ovarian cancer and breast cancer patients. Voprosy onkologii. 67, 2 (May 2022), 260–267. DOI:https://doi.org/10.37469/0507-3758-2021-67-2-260-267.